BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IBR733 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of IBR733\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06234904-2907@assetmemo.bio
DTSTAMP:20261121T005350Z
DTSTART;VALUE=DATE:20270701
DTEND;VALUE=DATE:20270702
SUMMARY:IBR733: Phase 1 readout est. (NCT06234904)
DESCRIPTION:IBR733\, phase 1\, Acute Myeloid Leukemia.\nStudy: Study of IBR
 733 Cell Injection in Acute Myeloid Leukemia\nEstimated primary completion
 : 1 July 2027. This is a ClinicalTrials.gov estimate\, not a confirmed rea
 dout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ibr733
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT062
 34904
URL:https://assetmemo.bio/drug/ibr733#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
